Literature DB >> 11796959

Effect of tissue injury on D-Dimer levels: a prospective study in trauma patients.

Samir Johna1, Samuel Cemaj, Thomas O'Callaghan, Richard Catalano.   

Abstract

BACKGROUND: D-Dimer measurement has been used as a simple, non-invasive test to rule out thromboembolic phenomena in patients at risk for deep venous thrombosis (DVT) and / or pulmonary embolism (PE). Elevated D-Dimer level caused by tissue injury is believed to show a trend for gradual decrease to normal within the first three days after trauma. MATERIAL/
METHODS: To study the effect of tissue injury on D-Dimer levels, we conducted a prospective measurement of D-Dimer levels in severely traumatized, high-risk patients for DVT or PE, starting within 24 hours after admission until disposition of the patient or to a total of 14 days of hospitalization. Patients were observed clinically for development of thromboembolic phenomena, and were subjected to weekly surveillance using duplex scan of the lower extremities. Additional testing was done if requested by the attending trauma surgeon.
RESULTS: A total of 21 patients were enrolled in the study. There were 17 males, and 4 females. Patients had a mean age of (42) with a range of (17-79), and a mean ISS score of (20) with a range of (4-50). Seven patients completed 3-9 days of testing. Fourteen patients had more than 10 days of testing. Nine patients completed 14 days of testing. In all patients, tissue injury resulted in increased levels of D-Dimer above a threshold (500 ng/ml), below which DVT or PE can be ruled out. The increased levels failed to normalize even when testing was continued for 14 days.
CONCLUSIONS: In our study, the increased D-Dimer levels induced by tissue injury failed to show a trend of gradual return to normal within three days after trauma, as currently believed. This, in our opinion, may eliminate our ability to use D-Dimer testing to rule out DVT or PE in a subset of severely traumatized patients in the early post trauma period.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796959

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

1.  [D-dimer screening in surgical long-term intensive care patients].

Authors:  P Hilbert; K Zur Nieden; R Stuttmann
Journal:  Anaesthesist       Date:  2005-03       Impact factor: 1.041

2.  Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.

Authors:  Yong Yang; Gangning Feng; Jiangbo Yan; Long Wu; Faxuan Wang; Dong Ding; Hui Wang; Qunhua Jin
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

3.  The incidence of deep venous thrombosis before arthroscopy among patients suffering from high-energy knee trauma.

Authors:  Zhen Rong; Yao Yao; Dongyang Chen; Kai Song; Minghao Zheng; Qing Jiang
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-03-12       Impact factor: 4.342

4.  D-Dimer and Fibrin Degradation Products Impair Platelet Signaling: Plasma D-Dimer Is a Predictor and Mediator of Platelet Dysfunction During Trauma.

Authors:  Christopher C Verni; Antonio Davila; Carrie A Sims; Scott L Diamond
Journal:  J Appl Lab Med       Date:  2020-11-01

5.  Correlation Between D-Dimer Level and Deep Venous Thrombosis in Patients With Acute Spinal Cord Injuries.

Authors:  Jang Hyuk Cho; Jong Bum Kim; Dong Gyu Lee
Journal:  Am J Phys Med Rehabil       Date:  2020-07       Impact factor: 3.412

6.  Large D-Dimer Fluctuation in Normal Pregnancy: A Longitudinal Cohort Study of 4,117 Samples from 714 Healthy Danish Women.

Authors:  Katrine K Hedengran; Malene R Andersen; Steen Stender; Pal B Szecsi
Journal:  Obstet Gynecol Int       Date:  2016-04-17

7.  Risk assessment and management of preoperative venous thromboembolism following femoral neck fracture.

Authors:  Ze-Nan Xia; Ke Xiao; Wei Zhu; Bin Feng; Bao-Zhong Zhang; Jin Lin; Wen-Wei Qian; Jin Jin; Na Gao; Gui-Xing Qiu; Xi-Sheng Weng
Journal:  J Orthop Surg Res       Date:  2018-11-20       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.